AI Proteins

4:45 PM - 5:00 PM (EDT), Wednesday, June 7, 2023 ・ Session Room 104C
AI Proteins is re-imagining the possibilities of protein therapeutics by rationally designing entirely new proteins to carry out specific therapeutic functions. Using AI-based design and a high-throughput drug discovery platform, AI proteins creates synthetic proteins from scratch and optimizes a proteins activity for each therapeutic application. This engineering process enables the development of proteins that are inexpensive, durable, highly specific, and can be optimized for oral delivery.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Multiple Therapeutics
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
CSO. President
AI Proteins